Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series: World’s leading Event Organizer
Omics International publishes 98 Open Access Articles in 3 International Journals it has 2 Upcoming Conferences and 3 Previous Conferences with 147 Conference Proceedings and 31 National symposiums so far in the field.
Schizophrenia requires lifelong treatment, even when symptoms have subsided. Treatment with medications and psychosocial therapy can help manage the condition. During crisis periods or times of severe symptoms, hospitalization may be necessary to ensure safety, proper nutrition, adequate sleep and basic hygiene.
A psychiatrist experienced in treating schizophrenia usually guides treatment. The treatment team also may include a psychologist, social worker, psychiatric nurse and possibly a case manager to coordinate care. The full-team approach may be available in clinics with expertise in schizophrenia treatment.
OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that OMICS Group hosts over 700 edge peer reviewed Open Access Journals which contains over 75000 eminent personalities, reputed scientists as editorial board members. Omics International organizes over more than 1000 Global Events annually with support from 1000 more scientific Societies. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board that ensure a quality and quick review process checker.
These newer, second-generation medications are generally preferred because they pose a lower risk of serious side effects than do conventional medications. They include:
5th Neurology Congress
March 14-16, 2016 London, UK
2nd Brain Disorders Conference
October 27-29, 2016 Chicago, USA
4th Vascular Dementia Conference
June 30-July 2, 2016 Valencia, Spain
3rd Euro Psychiatry Conference
September 7-9, 2016 Amsterdam, Netherlands
May 5-6, 2016 Chicago, USA
6th World Neurological conference
May 19-21, 2016 San Antonio, USA
10th International Conference on Front temporal Dementias
31 August - 2 September 2016 Munich, Germany
The International Society of Vascular Behavioural and Cognitive Disorders Conference
12 - 15 October 2016 Amsterdam, the Netherlands
14th International Athens/Springfield Symposium on Advances in Alzheimer Therapy
9-12 March 2016 Athens, Greece 24-28 July 2016 Toronto, Canada
Alzheimer's Association International Conference
22-28 July 2016, Toronto, Canada
31st International Conference of Alzheimer's disease International
21 - 24 April 2016 Budapest, Hungary
Relevant Society and Associations:
Schizophrenia is a serious mental disorder that distorts with a person’s ability to thinks clearly, expresses emotions, make decisions and relate to others. Schizophrenia is a lifelong disease that cannot be cured but can be controlled with proper treatment. The course of mental illness is unique for each person and schizophrenia can leave its sufferer frightened and withdrawn. Based on symptoms schizophrenia are divided in to Disorganized schizophrenia, paranoid schizophrenia, catatonic schizophrenia, residual schizophrenia and undifferentiated schizophrenia. Schizophrenia is a term given to complex group of mental disorders.
Schizophrenia can be assessed by doctors through interviews with the patient as well as with family problems and friends. There is no brain imaging or single laboratory for diagnosis of schizophrenia. The positive or psychotic symptoms of schizophrenia are hallucinations and delusions, disorganized speech and behavior, lack of motivation and emotional expression, lack of energy and poor grooming habits. By observing the psychotic symptoms, schizophrenia can be diagnosed. The causes for schizophrenia are combination of environmental and genetic factors. The schizophrenia treatment includes therapy and medications to reduce the risk of symptoms. Antipsychotic medication frequently helps to relieve delusions and hallucinations. The effective treatment of schizophrenia is by therapy which includes cognitive behavioral therapy and electroconvulsive therapy.
Schizophrenia Medicine is the medicines are used to treat the symptoms of schizophrenia and schizophrenia related disorders. One of the best methods for treatment of schizophrenia is through medicines. The medications used to treat schizophrenia are antipsychotic medicines, mood stabilizing medicines, tricyclic depressants and selective serotonin reuptake inhibitors. The conventional typical antipsychotics are Haloperidol, chlorpromazine, fluphenazine and perphenazine. The other atypical antipsychotics are Lurasidone, paliperidone, ziprasidone, olanzapine and risperidone. Schizophrenia disease cannot be cured by medication but can be reduce the symptoms of schizophrenia.
National Symposium and Workshops on Schizophrenia medicine, which brings together leading schizophrenia pioneers from around the globe to exchange and present ideas and foster relationships among professionals. Schizophrenia medicine conference meeting features nationally and internationally known researchers and physicians who present new approaches to optimize neurological, immunological, mental effects of schizophrenia. Schizophrenia medicine Conference provides information on new formulations for the new drugs and their importance, mechanism of action, side effects. Around 16 National symposiums and Workshops are going to be held across the globe which includes “International Congress on Schizophrenia Research”, European conference on Schizophrenia Research” and many more.
Symptoms begin typically in young adulthood, and about 0.3–0.7% of people are affected during their lifetime. In 2013 there was estimated to be 23.6 million cases globally. The disorder is thought to mainly affect the ability to think, but it also usually contributes to chronic problems with behaviour and emotion. People with schizophrenia are likely to have additional conditions, including major depression and anxiety disorders; the lifetime occurrence of substance use disorder is almost 50%. Social problems, such as long-term unemployment, poverty, and homelessness are common. The average life expectancy of people with the disorder is ten to twenty five years less than the average life expectancy. This is the result of increased physical health problems and a higher suicide rate. In 2013 an estimated 16,000 people died from behaviour related-to or caused by schizophrenia.
This page will be updated regularly.
This page was last updated on 11th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising